Overview

Update
Status
Acquired by on December 23, 2009
Total Equity Funding
$23M in 1 Round from 3 Investors
Headquarters:
San Carlos, California
Description:
Corthera is engaged in acquiring, developing and commercializing therapies for illnesses in the acute care setting.
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://www.corthera.com

Company Details

Update

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Funding Rounds (1) - $23M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2007$23M / Series C3

Offices/Locations (1)

Update
  • Office

    150 Industrial Road

    c/o Novartis

    San Carlos, California 94070

    United States

Past Team (6)

Update

Images (1)

Update

Add Acquisitions

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos